You are here: Home > New Medications

4 New Medications

At WeightLoss MD we have an in-house pharmacy where we dispense a wide variety of FDA approved weight loss medications (if appropriate) for our patients. The cost of these medications that we dispense is included in your provider visit.

There are four new medications listed below that we do not dispense but, if you are interested, we are happy to discuss them with you at your next visit. If one of these new drugs is right for you then we can write a prescription that you can take to an outside pharmacy at an additional cost to you.

Which, if any, is right for you?

All four drugs help some people lose weight. None of the drugs is for everyone and they are all quite different.

Saxenda is the fourth drug for weight loss approved by the FDA since 2012. It's already available in a lower dose as Victoza for type 2 diabetes.Researchers began to study it as an obesity treatment after people on Victoza reported weight loss. Saxenda, like Victoza, is injected daily. It's approved for people with a body mass index (BMI) of 30, considered obese, or a BMI of 27 with weight-related conditions such as high blood pressure. It's meant to be used with exercise and a reduced-calorie diet.

Contrave is approved those who are obese and also for those who are overweight with risk factors such as high blood pressure, high cholesterol, or diabetes.
Contrave combines two drugs already on the market: bupropion (Wellbutrin), an antidepressant, and naltrexone, an anti-addiction drug. Because it contains bupropion, Contrave has a boxed warning to alert doctors and patients to the increased risk of suicidal thoughts that are linked with antidepressants.

Qsymia (kyoo-sim-EE-uh) is taken once a day, and uses a one-two punch to spur weight loss. It combines low doses of topiramate, used to treat seizures and migraines, and phentermine, a currently available mild stimulant approved by the FDA for weight loss. Phentermine suppresses appetite soon after the pill is taken, and topiramate (which kicks in later in the day) creates a sense of feeling full. In the FDA reviewed clinical trials, Qsymia has been proven to help patients lose between 10% and 15% of their body weight over a year's period as well as improve various cardiovascular aspects. Further studies have shown that this mixture has also had good results when studied as a sleep apnea treatment.

Belviq (BEL-VEEK) works by targeting specific serotonin receptors in the brain linked with feelings of satiety, leading patients to feel full. The FDA has approved Beviq for adults who are obese or who are overweight and have at least one serious medical condition, such as diabetes or high cholesterol. The approved labeling for Belviq also recommends that people discontinue the drug if they fail to lose 5% of their body weight after 12 weeks as longer treatment is unlikely to lead to meaningful weight loss. Belviq is classified as a Schedule IV controlled substance, which means it has a low potential for abuse.

WeightLoss MD will be following these new drugs very closely. Please feel free to sign up for our newsletter for announcements.